Published in Healthcare Mergers, Acquisitions and Ventures Week, December 9th, 2006
Tillotson is the only nonmedical doctor from industry to be inducted into the College.
Tillotson joined Replidyne in April 2006 with nearly 20 years comprehensive pharmaceutical experience, mainly in the field of anti-infectives. While with Bayer Pharmaceuticals, Tillotson was instrumental in the development of ciprofloxacin and moxifloxacin. After leaving Bayer, he served as a consultant, helping to form biotech company Oscient following the merger of Genesoft and Genome...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.